PathologyWatch Competitors

PathAI's mission is to improve patient outcomes with AI-powered pathology. Our platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine learning. We are a company of diverse employees with a wide range of backgrounds and experiences. Our world class team is passionate about solving challenging problems and making a huge impact. Our office is located in the heart of Fenway. PathAI was recently voted one of BBJ's Best Places to Work!

We are a leading provider of AI-driven precision pathology software for research and diagnostics. In research, we are a technology leader providing image analysis software that helps scientists, pathologists, and image analysis experts generate accurate and reproducible data for all types of tissue-based research. In diagnostics, we are a leader within clinical applications, with no less than nine diagnostic algorithms cleared under IVDR for EU customers. These applications provide diagnostic decision support and and can be easily activated and integrated into existing lab workflows. Founded in 2002, we are privately owned and operate internationally with over 750 customer accounts in more than 40 countries. Our company’s headquarters are located in Denmark’s Medicon Valley, with offices in Sweden, the UK, Germany, the Netherlands, and the United States, and local representation in France and China.

Proscia brings enterprise-grade intelligence to pathology, powering precision medicine from discovery to diagnosis. Our Concentriq platform is built for the people behind the most critical decisions in medicine. Pathologists, researchers, and laboratory leaders rely on Proscia to work faster, more accurately, and at scale. 16 of the top 20 pharmaceutical companies and a global laboratory network delivering 8M+ diagnoses annually trust Proscia every day. We are #1 Best in KLAS in the US and Europe, FDA 510(k) cleared, and CE-IVDR certified.